Literature DB >> 28735765

Incidental durotomy during total en bloc spondylectomy.

Noriaki Yokogawa1, Hideki Murakami2, Satoru Demura1, Satoshi Kato1, Katsuhito Yoshioka1, Hiroyuki Tsuchiya1.   

Abstract

BACKGROUND CONTEXT: The incidence of incidental durotomy (ID) during total en bloc spondylectomy (TES) tends to be higher than that during other spinal surgeries because of the peculiarities of TES, including its highly invasive nature, epidural tumor extension, and use in patients who often have complicated medical backgrounds. However, there have been no detailed reports on ID associated with TES.
PURPOSE: The study aimed to investigate ID during TES in detail. STUDY
DESIGN: This is a retrospective review of prospectively collected data. PATIENT SAMPLE: The study included 105 consecutive patients with spinal tumor who underwent TES between May 2010 and February 2015 (59 men, 46 women; mean age, 54.0 years [range, 14-75 years] at the time of surgery). OUTCOME MEASURES: Outcome measures included the incidence, risk factors, anatomical location, intraoperative maneuvers, and postoperative course of ID associated with TES.
MATERIALS AND METHODS: Medical and operative records and imaging findings were reviewed. Univariate analysis and multivariable stepwise logistic regression models were used to identify independent risk factors for ID.
RESULTS: Incidental durotomy occurred in 18 (17.1%) of the 105 patients. The univariate and multivariate analyses demonstrated that older age (adjusted odds ratio [aOR], 6.09; 95% confidence interval [CI], 1.17-31.76; p=.03), radiotherapy (RT) history (aOR, 5.31; 95% CI, 1.46-19.49; p=.01), and revision surgery (aOR, 19.42; 95% CI, 3.46-109.14; p<.01) were independent risk factors for ID. Incidental durotomy was more likely to occur during dissection of tumor tissues in proximity to the nerve root. Although all of the ID cases were primarily sutured and covered with polyglycolic acid mesh and fibrin glue spray, eight cases required additional intervention because of intractable postoperative cerebrospinal fluid leakage. Six of these eight had a history of RT.
CONCLUSIONS: Our results may help better identify high-risk patients for ID during TES, which may aid surgeons with optimal surgical decision making and in counseling patients on perioperative complications.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anatomical location; Incidental durotomy; Intraoperative maneuver; Multivariate analysis; Postoperative course; Radiotherapy; Risk factor; Total en bloc spondylectomy

Mesh:

Substances:

Year:  2017        PMID: 28735765     DOI: 10.1016/j.spinee.2017.07.169

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  4 in total

1.  En bloc spondylectomy in patients older than 60 years: indications, results and complications in a series of 37 patients.

Authors:  Carmine Zoccali; Gennaro Scotto; Luca Cannavò; Jacopo Baldi; Ulrica Scaffidi-Argentina; Alessandro Luzzati
Journal:  Eur Spine J       Date:  2019-04-10       Impact factor: 3.134

2.  Incidence of Unrecognized Incidental Durotomy during Surgery for Malignant Spinal Tumor.

Authors:  Takuma Koyama; Shurei Sugita; Takahiro Hozumi; Masanori Fujiwara; Kiyofumi Yamakawa; Tomotake Okuma; Takahiro Goto
Journal:  Spine Surg Relat Res       Date:  2019-11-01

3.  Risk factors and management strategies for cerebrospinal fluid leakage following lumbar posterior surgery.

Authors:  Jin Tang; Qilin Lu; Ying Li; Congjun Wu; Xugui Li; Xuewen Gan; Wei Xie
Journal:  BMC Surg       Date:  2022-01-29       Impact factor: 2.102

4.  Radiation Disrupts the Protective Function of the Spinal Meninges in a Mouse Model of Tumor-induced Spinal Cord Compression.

Authors:  Takaki Shimizu; Satoru Demura; Satoshi Kato; Kazuya Shinmura; Noriaki Yokogawa; Noritaka Yonezawa; Norihiro Oku; Ryo Kitagawa; Makoto Handa; Ryohei Annen; Takayuki Nojima; Hideki Murakami; Hiroyuki Tsuchiya
Journal:  Clin Orthop Relat Res       Date:  2021-01-01       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.